News
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a ...
Obituary: Terrie Lilly LEWISTON - Terrie Lilly, a devoted librarian, loving mother, and lifelong advocate for childhood literacy, passed away peacefully at Andwell Hospice ...
Lilly Pulitzer's Crazy Summer Sale Has Finds Starting at Just $5: Shop Dresses, Swimwear and More This is the time to save big at Lilly Pulitzer.
Eli Lilly's valuation might be a significant stumbling block for some investors. If the stock fails to meet the market's lofty expectations, its shares will plummet.
Evangeline Lilly has cancelled an appearance at the Italian Global Series Festival as she recuperates from a recent fall.
Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug's blockbuster potential in the company's ...
The latest Lilly Pulitzer Reserve Collection offers heirloom-quality dresses, tops, and matching sets. Shop the limited-edition drop here.
The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio.
Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long-term ...
Eli Lilly LLY 1.34% agreed to acquire Verve Therapeutics VERV -0.37% for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.
Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results